About the Vernix Caseosa Session
Vernix caseosa is a cream-like substance secreted by the skin of a fetus in the womb. It is composed of fatty white or yellowish-white sebum, lanugo (fetal hair), and cellular debris from epidermal skin cells. It is thought to provide protection from the amniotic fluid, and promotes the transition to life outside the womb by increasing hydration of the skin, regulating skin temperature, providing antimicrobial protection, and aiding in desquamation of the fetal skin. Vernix caseosa is most prominent around the time of birth, especially in premature infants. It can be observed covering the face or scalp or increases of the body, like the neck, underarms, and hands. As babies age, it will start to disappear, typically after day 2 to 5 after birth. It has been described as appearing cheese-like due to its composition, but may vary in texture, from a thick paste to a slimy material. It can also vary in color from white to yellow-brown, though bloodstains may give it a reddish hue. There are several areas of research into the role and function of vernix caseosa, including its role in preventing UVC-induced neonatal skin damage, as well as its use in alleviating symptoms of certain dermatological conditions. There have been several studies that suggest vernix caseosa has antimicrobial properties that help protect the skin from infection and inflammation. The primary role of vernix caseosa is to ensure neonatal skin hydration, regulation of temperature, and a protective function to baby from environmental hazards, particularly ultraviolet (UV) radiation. Its role in promoting desquamation of the fetal skin has been the subject of much research as well. Additionally, there is evidence that suggests vernix caseosa may be effective in treating skin disorder and diseases, such as eczema, psoriasis, and atopic dermatitis. All in all, vernix caseosa plays a vital role in providing the newborn with optimal physiological and protective advantages as they transition from life in the womb to life outside the womb.
Featured Speakers — Vernix Caseosa 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Vernix Caseosa Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Vernix Caseosa Conference 2027
Present Your Research
Oral and poster slots for original Vernix Caseosa work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Vernix Caseosa research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same program, same certificate.
Join IDC 2027 for the Vernix Caseosa track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Vernix Caseosa Conference 2027 — FAQs
What is the Vernix Caseosa track at IDC 2027?
The Vernix Caseosa track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Vernix Caseosa. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Vernix Caseosa sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Vernix Caseosa are all welcome — whether presenting or attending.
Can I present my research in the Vernix Caseosa track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Vernix Caseosa sessions?
Yes. IDC 2027 is a hybrid conference — attend the Vernix Caseosa track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.

